BioNTech SE
Stocks making the biggest moves in the premarket: Palantir, Rivian, Uber and more
Take a look at some of the biggest movers in the premarket: Palantir Technologies (PLTR) – The data analytics software company’s shares plunged 15.1% in premarket trading after posting a mixed quarter. Palantir reported profit of 2 cents per share, compared to a 4 cents a share consensus estimate. Revenue was higher than expected, however, […]
Read More
Cramer’s week ahead: Own recession-proof names and have cash ready for when stocks ‘come roaring back’
CNBC’s Jim Cramer said Friday that enduring the current market is a waiting game for a rally — and investors need to be prepared for when that happens. “Your portfolio should be split among some cash and some stocks that can thrive in a recession. … You need to accept the fact that we’re simply […]
Read More
Time for a fourth Covid vaccine dose? Here’s why medical professionals are skeptical
There hasn’t been enough research on how much protection a fourth dose can offer, medical professionals told CNBC. Justin Sullivan | Getty Images Countries are beginning to offer a fourth dose of the Covid-19 vaccine to vulnerable groups, but medical professionals are undecided on whether it would benefit the wider population. The U.S. Food and […]
Read More
Pfizer asks FDA to authorize third dose for children 5 to 11 years old
Dr. Sandra Hughes prepares to administer a first dose of the Pfizer-BioNTech coronavirus vaccine (COVID-19) to Elise Langevina, 6, in Storrs, Connecticut, U.S., November 3, 2021. Michelle McLoughlin | Reuters Pfizer and BioNTech on Tuesday asked the Food and Drug Administration to authorize a third dose of its Covid vaccine for children ages 5- to […]
Read More
Stocks making the biggest moves midday: Robinhood, Chewy, RH, Lululemon and more
Vlad Tenev, CEO and co-founder Robinhood Markets, Inc., is displayed on a screen during his company’s IPO at the Nasdaq Market site in Times Square in New York City, U.S., July 29, 2021. Brendan McDermid | Reuters Check out the companies making headlines in midday trading. Robinhood — Shares of the stock-trading app fell 5.8% […]
Read More
Stocks making the biggest moves premarket: BioNTech, Five Below, Lululemon and others
Check out the companies making headlines before the bell: BioNTech (BNTX) – The drug maker’s shares jumped 5.9% in the premarket after reporting significantly better-than-expected revenue and profit for the fourth quarter. BioNTech also reiterated its prior vaccine revenue guidance for 2022. Five Below (FIVE) – The discount retailer’s stock slid 3.4% in premarket trading […]
Read More
Moderna Covid vaccine for kids under 6 years old was up to 44% effective against omicron infection
With her husband Stephen by her side Erin Shih hugs her children Avery 6, and Aidan, 11, after they got their second Moderna COVID-19 vaccines at Kaiser Permanente Los Angeles Medical Center on Friday, June 25, 2021. Sarah Reingewirtz | MediaNews Group | Getty Images Moderna’s two-dose Covid vaccine was about 44% effective at preventing […]
Read More
Stocks making the biggest moves midday: GameStop, Tesla, FedEx and more
Shoppers wait for a GameStop store to open on at the Tysons Corner Center, in Tysons, Virginia, November 27, 2020. Hannah McKay | Reuters Check out the companies making headlines in midday trading Friday. GameStop — Shares of the video game retailer gained about 2%, erasing big overnight losses, as investors looked past the company’s […]
Read More
Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021
Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys | Pool | Reuters Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase […]
Read More
Stocks making the biggest moves premarket: FedEx, GameStop, Moderna and more
Check out the companies making headlines before the bell: FedEx (FDX) – FedEx earned an adjusted $4.59 per share for its latest quarter, missing estimates by 5 cents, though the delivery service’s revenue beat analyst forecasts. FedEx’s bottom line was impacted by worker shortages stemming from the Covid-19 omicron variant outbreak during the quarter. FedEx […]
Read More